Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, SeaStar Medical Holding Corp (NASDAQ: ICU) closed at $0.92 down -0.04% from its previous closing price of $0.92. In other words, the price has decreased by -$0.04 from its previous closing price. On the day, 1.86 million shares were traded. ICU stock price reached its highest trading level at $0.945 during the session, while it also had its lowest trading level at $0.8651.
Ratios:
For a deeper understanding of SeaStar Medical Holding Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.52. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 26 ’25 when Van Heel Kenneth bought 25,000 shares for $0.89 per share. The transaction valued at 22,248 led to the insider holds 39,400 shares of the business.
Van Heel Kenneth bought 10,000 shares of ICU for $8,565 on Aug 27 ’25. The Director now owns 49,400 shares after completing the transaction at $0.86 per share. On Aug 22 ’25, another insider, Chung Kevin, who serves as the Chief Medical Officer of the company, bought 10,000 shares for $0.80 each. As a result, the insider paid 8,000 and bolstered with 58,184 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ICU now has a Market Capitalization of 25561400 and an Enterprise Value of 19259396. For the stock, the TTM Price-to-Sale (P/S) ratio is 33.19 while its Price-to-Book (P/B) ratio in mrq is 4.75. Its current Enterprise Value per Revenue stands at 25.143.
Stock Price History:
The Beta on a monthly basis for ICU is -0.97, which has changed by -0.8255238 over the last 52 weeks, in comparison to a change of 0.16222072 over the same period for the S&P500. Over the past 52 weeks, ICU has reached a high of $5.79, while it has fallen to a 52-week low of $0.31. The 50-Day Moving Average of the stock is 32.01%, while the 200-Day Moving Average is calculated to be -36.96%.
Shares Statistics:
For the past three months, ICU has traded an average of 7.62M shares per day and 1170230 over the past ten days. A total of 27.91M shares are outstanding, with a floating share count of 26.81M. Insiders hold about 3.96% of the company’s shares, while institutions hold 1.73% stake in the company. Shares short for ICU as of 1755216000 were 1597304 with a Short Ratio of 0.21, compared to 1752537600 on 575798. Therefore, it implies a Short% of Shares Outstanding of 1597304 and a Short% of Float of 5.75.
Earnings Estimates
SeaStar Medical Holding Corp (ICU) is currently under the scrutiny of 1.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.17 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.77 and -$0.77 for the fiscal current year, implying an average EPS of -$0.77. EPS for the following year is -$0.46, with 1.0 analysts recommending between -$0.46 and -$0.46.
Revenue Estimates
A total of 1 analysts believe the company’s revenue will be $300k this quarter.It ranges from a high estimate of $300k to a low estimate of $300k. As of the current estimate, SeaStar Medical Holding Corp’s year-ago sales were $68kFor the next quarter, 1 analysts are estimating revenue of $400k. There is a high estimate of $400k for the next quarter, whereas the lowest estimate is $400k.
A total of 1 analysts have provided revenue estimates for ICU’s current fiscal year. The highest revenue estimate was $1.33M, while the lowest revenue estimate was $1.33M, resulting in an average revenue estimate of $1.33M. In the same quarter a year ago, actual revenue was $135kBased on 1 analysts’ estimates, the company’s revenue will be $2.28M in the next fiscal year. The high estimate is $2.28M and the low estimate is $2.28M.
